Brief: COMPASS Pathways Q3 EPS USD -1.44
04/11/2025 11:30
Nov 04 (Reuters) - COMPASS Pathways Q3 operating expenses USD 40.536 million. Q3 net income USD -137.717 million Q3 pretax profit USD -137.947 million Q3 operating income USD -40.536 million vs. IBES estimate USD -42.7 million
Recent news on COMPASS Pathways
See all newsCompass Pathways PLC reports results for the quarter ended September 30 - Earnings Summary
Corrected: Compass Pathways Q3 net loss narrows on lower R&D charges
Corrected: BRIEF-COMPASS Pathways Q3 EPS USD -0.31
Psychedelic drug developers fall after Usona submits depressive drug application
Compass Pathways PLC expected to post a loss of 45 cents a share - Earnings Preview